| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451800 Phenylpiperazine derivatives as integrin αvβ3 antagonists |
| 09/17/2002 | US6451792 Matrix metalloprotease inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451740 Uracil compounds and use thereof |
| 09/17/2002 | US6451737 N-(4,6-dimethyl-pyrimidin-2-yl)-n'-(2-methoxy-6-trifluoromethy l-phenylsulphonyl)-urea |
| 09/17/2002 | US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 09/17/2002 | CA2057338C Diarylfluoromethane compounds |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 09/12/2002 | WO2002070483A1 Heterocyclic diamide invertebrate pest control agents |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2002026717A3 Hydroxy acid integrin antagonists |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | WO2001045641A3 Inhibitors of thrombin induced platelet aggregation |
| 09/12/2002 | US20020128553 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/12/2002 | US20020128434 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/12/2002 | US20020128279 Potassium channel blocking agents |
| 09/12/2002 | US20020128269 Piperazine derivatives |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2437840A1 Heterocyclic diamide invertebrate pest control agents |
| 09/11/2002 | EP1237879A1 Phenoxy and thiophenoxy acrylic acid compounds as herbicides |
| 09/11/2002 | EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237554A2 Use of sodium channel antagonists for the treatment of diseases related to apoptosis |
| 09/11/2002 | EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 09/11/2002 | CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/11/2002 | CN1368956A Carbamate derivatives and agricultural/horticultural bactericides |
| 09/11/2002 | CN1368952A 1,4-substituted 4,4-diaryl cyclohexanes |
| 09/11/2002 | CN1090655C Dyestuffs |
| 09/11/2002 | CN1090621C Process for producing quinazoline-4-one derivatives |
| 09/10/2002 | US6448408 Process for the preparation of heteroaryl-phenylalanines |
| 09/10/2002 | US6448403 Dehalogenation and amination to synthesize such as 4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino)-2-cyclopentene-1 -methanol; chemical intermediates for purine nucleoside analogues |
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448256 Precursors of n-substituted derivatives of 6-aminouracils, 6-aminoisocytosines, guanines and 2-aminoadenines having a cleavable ester group; greater water solubility and oral bioavailability; treating gram positive bacterial infections |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase |
| 09/06/2002 | WO2002068413A1 Pyrazolyl pyrimidines |
| 09/06/2002 | WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068396A1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties |
| 09/06/2002 | WO2002068367A1 A method to inhibit ethylene responses in plants |
| 09/06/2002 | WO2002068057A1 Barbiturates as integrin antagonists and their use for treating inflammatory diseases |
| 09/06/2002 | WO2002067998A2 Devices and methods for the treatment of cancer |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002048115A3 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests |
| 09/06/2002 | WO2002033025A3 C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/06/2002 | WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/06/2002 | WO2001090071A3 Substituted iminoazines used as herbicides |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2439143A1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties |
| 09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/05/2002 | US20020123502 5-(4-(2-(2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl) -ethoxy)phenyl methyl)thiazolidine-2,4-dione for example; also oxazolidine-2,4-dione, and 1,2,4-oxadiazolidine-3,5-dione derivatives; reducing blood glucose levels |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123491 Selective neurokinin antagonists |
| 09/05/2002 | US20020121638 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 09/05/2002 | DE10108480A1 Pyrazolylpyrimidine Pyrazolylpyrimidine |
| 09/04/2002 | EP1236721A1 5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal compositions containing the same and intermediate of these compounds |
| 09/04/2002 | EP1236712A1 Amidinophenylpyruvic acid derivative |
| 09/04/2002 | EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235813A1 Hydroxamic acid derivatives |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1149066A4 Method of preparing alkylated salicylamides |
| 09/04/2002 | EP1080086B1 Dihydropyrimidines |
| 09/04/2002 | EP1005471B1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action |
| 09/04/2002 | EP0966476B1 Quinazolinone compounds |
| 09/04/2002 | EP0882043B1 Halogen pyrimidines and its use thereof as parasite abatement means |
| 09/04/2002 | EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds |
| 09/04/2002 | EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367769A Process for catalyzing oxidation of organic compounds |
| 09/04/2002 | CN1090178C Tricyclic compounds having activity specific for integrins, particularly alpha V beta 3 integrins, method for preparing same |
| 09/04/2002 | CN1090177C Preparation of aromatic nitriles |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | US6444816 Dietetics, anticholesterol agents, antidiabetic agents |
| 09/03/2002 | US6444815 Method for producing heteroaromatic aldehydes |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444674 High affinity for the dopamine d3 receptor; schizophrenia, depression, neuroses and psychoses |
| 09/03/2002 | US6444616 Substituted p-trifluoromethylphenyluracils |
| 09/03/2002 | US6444279 Liquid crystal propene or propenyl nitrile derivatives |
| 09/03/2002 | US6444278 2,6-di-tert-butylphenols |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 08/29/2002 | WO2002067053A2 High speed photothermographic materials containing tellurium compounds and methods of using same |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |